Lipoprotein metabolism disorder in type 2 DM is recognized as diabetic dyslipidemia. A key element in the multifactorial approach to prevent CVD in patients with type 2 diabetes is the management of diabetic dyslipidemia. Dyslipidemia contributes to a substantial percentage of cardiovascular mortality and morbidity in diabetic patients. This article describes the effective approach to the management of dyslipidemia in patients with diabetes.
In recent decades, the occurrence of diabetes has increased vividly all over India. As there are about 69 million people with diabetes in India, a higher number have pre-diabetes. The escalating prevalence of diabetes is soon to be followed by an increasing prevalence of diabetic complications. As a result, this increased trend highlights the significance of prevention and appropriate therapy to reduce cardiovascular events in patients with…
